Access cutting-edge methamphetamine use disorder treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access methamphetamine use disorder specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related methamphetamine use disorder treatment provided free
The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing methamphetamine (MA) use in individuals with moderate or severe methamphetamine use disorder (MUD) seeking to stop or reduce MA use.
Sponsor: National Institute on Drug Abuse (NIDA)
Check if you qualify for this methamphetamine use disorder clinical trial in Portland, OR
If you're searching for methamphetamine use disorder treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced methamphetamine use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.